Alcon (ALC) ROE % Adjusted to Book Value : 4.43% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Alcon ROE % Adjusted to Book Value?

Alcon's ROE % for the quarter that ended in Dec. 2023 was 8.28%. Alcon's PB Ratio for the quarter that ended in Dec. 2023 was 1.87. Alcon's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 4.43%.

Alcon ROE % Adjusted to Book Value Historical Data

The historical data trend for Alcon's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon ROE % Adjusted to Book Value Chart

Alcon Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-2.19

-1.63

0.89

1.01

2.58

Alcon Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-1.15	-	-	-	4.43

Competitive Comparison of Alcon's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Alcon's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alcon's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alcon's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alcon's ROE % Adjusted to Book Value falls into.

Alcon ROE % Adjusted to Book Value Calculation

Alcon's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	4.83%	/	1.87
	=	2.58%

Alcon's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	8.28%	/	1.87
	=	4.43%

Alcon ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alcon's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Alcon (ALC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (NYSE:ALC) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ALC:Mexico ALCz:UK 0A0D:UK ALC:Switzerland

Address

Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214

Website

https://www.alcon.com

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.